Dudediligence.

BioCardia, Inc

BCDANASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Sep ’24$0.00Dec ’24$0.00Mar ’25$0.00Jun ’25$0.00Sep ’25$0.00Dec ’25
Net income, by quarter
−$1.7MSep ’24−$2.3MDec ’24−$2.7MMar ’25−$2.0MJun ’25−$1.5MSep ’25−$2.0MDec ’25−$2.3MMar ’26−$1.6MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$1.0M$1.4M$477,000$58,000$0.00
Gross profit$1.0Mnone on filenone on filenone on filenone on file
Operating income−$12.6M−$11.9M−$11.6M−$8.0M−$8.3M
Net income−$12.6M−$11.9M−$11.6M−$7.9M−$8.2M
Operating cash flow−$10.4M−$10.6M−$10.0M−$7.9M−$7.4M
Free cash flow−$10.5M−$10.6M−$10.0M−$7.9M−$7.4M
Cash$12.9M$7.4M$1.1M$2.4M$2.5M
Shares outstanding16.9M20.1M23.7M4.6M10.8M